High residual C-peptide likely contributes to glycemic control in type 1 diabetes

Journal: Journal of Clinical Investigation

Published: 2020-04-01

DOI: 10.1172/jci134057

Affiliations: 9

Authors: 13

Go to article
Institutions Share
Benaroya Research Institute at Virginia Mason (BRI), United States of America (USA) 0.31
Center for Diabetes and Metabolic Diseases (CDMD), IUPUI, United States of America (USA) 0.15
Institute for Diabetes, Obesity and Metabolism (IDOM), Penn, United States of America (USA) 0.08
Children's Hospital Colorado, United States of America (USA) 0.08
Children's Mercy Hospitals and Clinics, United States of America (USA) 0.08
Yale School of Medicine (YSM), United States of America (USA) 0.08
Translational Research Institute for Metabolism and Diabetes (TRI), United States of America (USA) 0.08
Barbara Davis Center for Childhood Diabetes (BDC), United States of America (USA) 0.08
Jaeb Center for Health Research (JCHR), United States of America (USA) 0.08

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER